Workflow
Bristol Myers Squibb and RayzeBio Announce Expiration of HSR Act Waiting Period
BMYBristol-Myers Squibb(BMY) Businesswire·2024-02-12 19:59

PRINCETON, N.J. & SAN DIEGO--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) and RayzeBio, Inc. (Nasdaq: RYZB) today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, or HSR Act, in connection with Bristol Myers Squibb’s previously announced tender offer to acquire all of the outstanding shares of RayzeBio common stock for a purchase price of 62.50pershareincash,orapproximately62.50 per share in cash, or approximately 4.1 billion. The expiration of the waiting period occurred a ...